Erratum to Chemokine decoy receptor d6 mimicking trap (D6MT) prevents allosensitization and immune rejection in murine corneal allograft model(Journal of Leukocyte biology, (2015), 10.1189/jlb.5A0414-233RR);Chemokine decoy receptor D6 mimicking trap (D6MT) prevents allosensitization and immune rejection in murine corneal allograft model

Journal of Leukocyte Biology

Volumn 97, Issue 2, 2015, Pages 413-424

  Choi, Wungrak ^a   Byun, Yu Jeong ^a   Jung, Eunae ^a   Noh, Hyemi ^a   Hajrasouliha, Amir R ^b   Sadrai, Zahra ^c   Chang, Eunju ^d   Lee, Joon H ^e   Lee, Hyung Keun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Louisville School of Medicine   (United States)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^d University of Ulsan College of Medicine   (South Korea)

^e Konyang University College of Medicine   (South Korea)

Author keywords

Transplantation

Indexed keywords

CHEMOKINE DECOY RECEPTOR D6 MIMICKING TRAP; CHEMOKINE RECEPTOR; FLUORESCEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BIOMIMETIC MATERIAL; CCBP2 PROTEIN, MOUSE; CCL2 PROTEIN, MOUSE; CCL3 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD CELL; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; CORNEAL ALLOGRAFT REJECTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; UPREGULATION; ALLOGRAFT; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY;

MURINAE;

ALLOGRAFTS; ANIMALS; BIOMIMETIC MATERIALS; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL5; CORNEAL TRANSPLANTATION; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; MALE; MICE; RECEPTORS, CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84925353073     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5A0414-233RR.err     Document Type: Erratum

References (51)

1. Saban, D. R., Bock, F., Chauhan, S. K., Masli, S., Dana, R. (2010) Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J. Immunol. 185, 4691–4697.
2. Niederkorn, J. Y., Larkin, D. F. (2010) Immune privilege of corneal allografts. Ocul. Immunol. Inflamm. 18, 162–171.
3. Chauhan, S. K., Saban, D. R., Lee, H. K., Dana, R. (2009) Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J. Immunol. 182, 148–153.
4. Hamrah, P., Yamagami, S., Liu, Y., Zhang, Q., Vora, S. S., Lu, B., Gerard, C. J., Dana, M. R. (2007) Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 48, 1228–1236.
5. Skelsey, M. E., Mellon, J., Niederkorn, J. Y. (2001) Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J. Immunol. 166, 4327–4333.
6. Hattori, T., Saban, D. R., Emami-Naeini, P., Chauhan, S. K., Funaki, T., Ueno, H., Dana, R. (2012) Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J. Leukoc. Biol. 91, 621–627.
7. Forrester, J. V., Xu, H., Kuffová, L., Dick, A. D., McMenamin, P. G. (2010) Dendritic cell physiology and function in the eye. Immunol. Rev. 234, 282–304.
8. Mantovani, A., Savino, B., Locati, M., Zammataro, L., Allavena, P., Bonecchi, R. (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 21, 27–39.
9. Pivarcsi, A., Müller, A., Hippe, A., Rieker, J., van Lierop, A., Steinhoff, M., Seeliger, S., Kubitza, R., Pippirs, U., Meller, S., Gerber, P. A., Liersch, R., Buenemann, E., Sonkoly, E., Wiesner, U., Hoffmann, T. K., Schneider, L., Piekorz, R., Enderlein, E., Reifenberger, J., Rohr, U. P., Haas, R., Boukamp, P., Haase, I., Nürnberg, B., Ruzicka, T., Zlotnik, A., Homey, B. (2007) Tumor immune escape by the loss of homeostatic chemokine expression. Proc. Natl. Acad. Sci. USA 104, 19055–19060.
10. Agrawal, A., Sridharan, A., Prakash, S., Agrawal, H. (2012) Dendritic cells and aging: consequences for autoimmunity. Expert Rev. Clin. Immunol. 8, 73–80.
11. Stoop, J. N., Robinson, J. H., Hilkens, C. M. (2011) Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models? Ann. Rheum. Dis. 70, 1526–1533.
12. Stegall, M. D., Dean, P. G., Gloor, J. (2009) Mechanisms of alloantibody production in sensitized renal allograft recipients. Am. J. Transplant. 9, 998–1005.
13. Rowshani, A. T., Vereyken, E. J. (2012) The role of macrophage lineage cells in kidney graft rejection and survival. Transplantation 94, 309–318.
14. Hamrah, P., Dana, M. R. (2007) Corneal antigen-presenting cells. Chem. Immunol. Allergy 92, 58–70.
15. Homey, B., Meller, S. (2008) Chemokines and other mediators as therapeutic targets in psoriasis vulgaris. Clin. Dermatol. 26, 539–545.
16. Rot, A., von Andrian, U. H. (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891–928.
17. Savino, B., Borroni, E. M., Torres, N. M., Proost, P., Struyf, S., Mortier, A., Mantovani, A., Locati, M., Bonecchi, R. (2009) Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence. J. Biol. Chem. 284, 26207–26215.
18. Nibbs, R. J., Wylie, S. M., Yang, J., Landau, N. R., Graham, G. J. (1997) Cloning and characterization of a novel promiscuous human betachemokine receptor D 6. J. Biol. Chem. 272, 32078–32083.
19. Lee, K. M., Nibbs, R. J., Graham, G. J. (2013) D6: the ‘crowd controller’ at the immune gateway. Trends Immunol. 34, 7–12.
20. Hajrasouliha, A. R., Sadrai, Z., Lee, H. K., Chauhan, S. K., Dana, R. (2013) Expression of the chemokine decoy receptor D6 mediates dendritic cell function and promotes corneal allograft rejection. Mol. Vis. 19, 2517–2525.
21. Liu, Y., Hamrah, P., Zhang, Q., Taylor, A. W., Dana, M. R. (2002) Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J. Exp. Med. 195, 259–268.
22. Ji, Y. W., Byun, Y. J., Choi, W., Jeong, E., Kim, J. S., Noh, H., Kim, E. S., Song, Y. J., Park, S. K., Lee, H. K. (2013) Neutralization of ocular surface TNF- a reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye. Invest. Ophthalmol. Vis. Sci. 54, 7557–7566.
23. Seo, Y., Ji, Y. W., Lee, S. M., Shim, J., Noh, H., Yeo, A., Park, C., Park, M. S., Chang, E. J., Lee, H. K. (2014) Activation of HIF-1a (hypoxia inducible factor-1a) prevents dry eye-induced acinar cell death in the lacrimal gland. Cell Death Dis. 5, e1309.
24. Lee, H. K., Chauhan, S. K., Kay, E., Dana, R. (2011) Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7- dependent pathway. Blood 117, 5762–5771.
25. Whitehead, G. S., Wang, T., DeGraff, L. M., Card, J. W., Lira, S. A., Graham, G. J., Cook, D. N. (2007) The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am. J. Respir. Crit. Care Med. 175, 243–249.
26. Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33.
27. Bradford, L., Marshall, H., Robertson, H., Kirby, J. A., Graham, G., Ali, S., O’Boyle, G. (2010) Cardiac allograft rejection: examination of the expression and function of the decoy chemokine receptor D6. Transplantation 89, 1411–1416.
28. Walsh, P. T., Strom, T. B., Turka, L. A. (2004) Routes to transplant tolerance versus rejection; the role of cytokines. Immunity 20, 121–131.
29. Pitchford, S. C., Furze, R. C., Jones, C. P., Wengner, A. M., Rankin, S. M. (2009) Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4, 62–72.
30. Pease, J. E., Horuk, R. (2009) Chemokine receptor antagonists: part 2. Expert Opin. Ther. Pat. 19, 199–221.
31. Horuk, R. (2009) Chemokine receptor antagonists: overcoming developmental hurdles. Nat. Rev. Drug Discov. 8, 23–33.
32. Jamieson, T., Cook, D. N., Nibbs, R. J., Rot, A., Nixon, C., McLean, P., Alcami, A., Lira, S. A., Wiekowski, M., Graham, G. J. (2005) The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6, 403–411.
33. McKimmie, C. S., Graham, G. J. (2006) Leucocyte expression of the chemokine scavenger D6. Biochem. Soc. Trans. 34, 1002–1004.
34. Madigan, J., Freeman, D. J., Menzies, F., Forrow, S., Nelson, S. M., Young, A., Sharkey, A., Moffett, A., Graham, G. J., Greer, I. A., Rot, A., Nibbs, R. J. (2010) Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J. Immunol. 184, 3202–3212.
35. Martinez de la Torre, Y., Buracchi, C., Borroni, E. M., Dupor, J., Bonecchi, R., Nebuloni, M., Pasqualini, F., Doni, A., Lauri, E., Agostinis, C., Bulla, R., Cook, D. N., Haribabu, B., Meroni, P., Rukavina, D., Vago, L., Tedesco, F., Vecchi, A., Lira, S. A., Locati, M., Mantovani, A. (2007) Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc. Natl. Acad. Sci. USA 104, 2319–2324.
36. Singh, M. D., King, V., Baldwin, H., Burden, D., Thorrat, A., Holmes, S., McInnes, I. B., Nicoll, R., Shams, K., Pallas, K., Jamieson, T., Lee, K. M., Carballido, J. M., Rot, A., Graham, G. J. (2012) Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am. J. Pathol. 181, 1158–1164.
37. Bordon, Y., Hansell, C. A., Sester, D. P., Clarke, M., Mowat, A. M., Nibbs, R. J. (2009) The atypical chemokine receptor D6 contributes to the development of experimental colitis. J. Immunol. 182, 5032–5040.
38. Pashover-Schallinger, E., Aswad, M., Schif-Zuck, S., Shapiro, H., Singer, P., Ariel, A. (2012) The atypical chemokine receptor D6 controls macrophage efferocytosis and cytokine secretion during the resolution of inflammation. FASEB J. 26, 3891–3900.
39. Schröppel, B., Fischereder, M., Lin, M., Marder, B., Schiano, T., Krämer, B. K., Murphy, B. (2002) Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients. J. Clin. Immunol. 22, 381–385.
40. Moench, C., Uhrig, A., Lohse, A. W., Otto, G. (2003) The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation. Transplant. Proc. 35, 1452–1455.
41. Niederkorn, J. Y. (2010) High-risk corneal allografts and why they lose their immune privilege. Curr. Opin. Allergy Clin. Immunol. 10, 493–497.
42. Koski, G. K., Karikó, K., Xu, S., Weissman, D., Cohen, P. A., Czerniecki, B. J. (2004) Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J. Immunol. 172, 3989–3993.
43. Merrick, A., Errington, F., Milward, K., O’Donnell, D., Harrington, K., Bateman, A., Pandha, H., Vile, R., Morrison, E., Selby, P., Melcher, A. (2005) Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming. Br. J. Cancer 92, 1450–1458.
44. Förster, R., Davalos-Misslitz, A. C., Rot, A. (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362–371.
45. Worbs, T., Förster, R. (2007) A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol. 28, 274–280.
46. de Mendonça, F. L., da Fonseca, P. C., Phillips, R. M., Saldanha, J. W., Williams, T. J., Pease, J. E. (2005) Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist. J. Biol. Chem. 280, 4808–4816.
47. Vedani, A., Dobler, M., Dollinger, H., Hasselbach, K. M., Birke, F., Lill, M. A. (2005) Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR. J. Med. Chem. 48, 1515–1527.
48. Haemmerle, M., Keller, T., Egger, G., Schachner, H., Steiner, C. W., Stokic, D., Neumayer, C., Brown, M. K., Kerjaschki, D., Hantusch, B. (2013) Enhanced lymph vessel density, remodeling, and inflammation are reflected by gene expression signatures in dermal lymphatic endothelial cells in type 2 diabetes. Diabetes 62, 2509–2529.
49. Xu, J., Zhang, C., He, Y., Wu, H., Wang, Z., Song, W., Li, W., He, W., Cai, S., Zhan, W. (2012) Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer. Int. J. Cancer 130, 787–797.
50. Cao, R., Eriksson, A., Kubo, H., Alitalo, K., Cao, Y., Thyberg, J. (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ. Res. 94, 664–670.
51. Mestas, J., Hughes, C. C. (2004) Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731–2738.